SHENZHEN SHENGLIJIAN BIO-TECHNOLOGY LIMITED – Trademark Portfolio

Entity Type: 99

SHENZHEN SHENGLIJIAN BIO-TECHNOLOGY LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include JURQEAR. The owner is based in FUTIAN DIST. SHENZHEN.

ROOM 708 EXCELLENCE CENTURY TOWER 3

INTERSECTION OF FUHUA RD. AND JINTIAN RD

FUTIAN DIST. SHENZHEN 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

JURQEAR
JURQEAR
Registered 2020

Trademark Classifications

SHENZHEN SHENGLIJIAN BIO-TECHNOLOGY LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does SHENZHEN SHENGLIJIAN BIO-TECHNOLOGY LIMITED have?

SHENZHEN SHENGLIJIAN BIO-TECHNOLOGY LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does SHENZHEN SHENGLIJIAN BIO-TECHNOLOGY LIMITED file in?

SHENZHEN SHENGLIJIAN BIO-TECHNOLOGY LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are SHENZHEN SHENGLIJIAN BIO-TECHNOLOGY LIMITED's most well-known trademarks?

SHENZHEN SHENGLIJIAN BIO-TECHNOLOGY LIMITED's registered trademark portfolio includes well-known marks such as JURQEAR. These are among 1 currently registered trademark in the portfolio.

What is SHENZHEN SHENGLIJIAN BIO-TECHNOLOGY LIMITED's trademark registration success rate?

SHENZHEN SHENGLIJIAN BIO-TECHNOLOGY LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.